Jordan S. Davis
Managing Partner and Co-Founder @ Radius Ventures
New York, United States
Jordan S. Davis is a Managing Partner and co-founder of Radius, which acts as the Investment Advisor to the Radius Funds. Jordan’s experience spans the founding of new ventures to growth capital stage investing in a broad range of innovative healthcare, medical technology and life sciences companies. Having begun his career at Morgan Stanley& Co., Jordan brings capital markets expertise and perspective to Radius’ portfolio companies as they navigate an increasingly complex and challenging financing environment. Prior to Radius, Jordan was a Managing Director at KBL Healthcare, Inc., a health and life sciences venture capital and investment banking firm, where he co-founded and served as Vice President and board member of KBL Healthcare Acquisition Corp. (KBLHAC), the first healthcare focused Special Purpose Acquisition Company (SPAC) designed to provide an alternative means for an emerging private healthcare company to access vital growth capital. Along these lines, KBLHAC successfully completed the acquisition of Concord Health Group, a rapidly growing operator of post-acute care nursing facilities and assisted living residences, where Jordan continued to serve as a board member until its ultimate acquisition by The Multicare Companies.As an entrepreneur, Jordan was a founder of Cambridge Heart, Inc., a cardiology diagnostics company that developed and commercialized breakthrough technology to non-invasively diagnose patients at risk of sudden cardiac death, and Voxware, Inc., a speech technology company and early entrant into the voice over IP market; both of these companies moved from start-up to IPO in three years. Jordan has served on numerous public and private company boards and currently serves on the board of directors of BioStorage Technologies, Inc., Minimally Invasive Devices, Inc. and Tactile Systems Technology, Inc., all Radius portfolio companies. In addition to his Radius boards, Jordan also serves on the board of directors of HealthCorps, a national non-profit peer mentoring organization cofounded by Dr. Mehmet Oz, dedicated to fighting childhood obesity through educating and empowering youth to take charge of their health.Jordan earned an M.B.A. from the Kellogg School of Management at Northwestern University and a B.A. in Economics from The State University of New York at Binghamton.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Jordan S. Davis invests in
Stages Jordan S. Davis invests in
Countries Jordan S. Davis invests in
Investment Focus
Industry
- Health Care 3 (50%)
- Medical 2 (33%)
- Biotechnology 2 (33%)
- Medical Device 2 (33%)
- Pharmaceutical 1 (17%)
Stage
- Series B 2 (33%)
- Series A 1 (17%)
- Series C 1 (17%)
- Funding Round 1 (17%)
- Debt Financing 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Minimally invasive devices
|
MID has developed the FloShield system, a franchise of products that substantially improve visualization during laparoscopic surgery. During laparoscopic surgery, it is common for condensation to form on the end of the laparoscope obscuring vision. It is also common for debris from the ultrasonic scalpel, cautery, or even blood products themselvesto degrade the surgical view. Most commonly, surgeons will need to remove the laparoscope for manual cleaning. It was founded in 2006 and headquartered in Columbus, Ohio. | $14.1M / Series C / Nov 19, 2015 | |
|
Minimally invasive devices
|
MID has developed the FloShield system, a franchise of products that substantially improve visualization during laparoscopic surgery. During laparoscopic surgery, it is common for condensation to form on the end of the laparoscope obscuring vision. It is also common for debris from the ultrasonic scalpel, cautery, or even blood products themselvesto degrade the surgical view. Most commonly, surgeons will need to remove the laparoscope for manual cleaning. It was founded in 2006 and headquartered in Columbus, Ohio. | $6M / Debt Financing / Jun 24, 2014 | |
|
Minimally invasive devices
|
MID has developed the FloShield system, a franchise of products that substantially improve visualization during laparoscopic surgery. During laparoscopic surgery, it is common for condensation to form on the end of the laparoscope obscuring vision. It is also common for debris from the ultrasonic scalpel, cautery, or even blood products themselvesto degrade the surgical view. Most commonly, surgeons will need to remove the laparoscope for manual cleaning. It was founded in 2006 and headquartered in Columbus, Ohio. | $2.5M / Series B / Jun 17, 2013 | |
Tactile Medical
|
Tactile Systems Technology is a Minneapolis, Minnesota-based company, dedicated to advancing the standard of care in treating edema and vascular diseases at home. They manufacture and market the Flexitouch® system, an innovative medical device developed for at–home treatment of lymphedema, chronic edema, and non–healing venous ulcers. | $10.4M / Series B / Oct 05, 2012 | |
Athersys
|
Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and improve the quality of human life. The product development portfolio of the Company includes MultiStem, a stem cell product, which is being developed as a treatment for multiple disease indications, and is beingevaluated in two ongoing clinical trials, and has been authorized for use in a third clinical trial. In addition, the Company is developing pharmaceuticals to treat indications such as obesity, certain cognitive and attention disorders, and narcolepsy or other forms of excessive daytime sleepiness. | $65M / Jun 12, 2007 | |
Biostorage Technologies
|
BioStorage Technologies is the premier, global provider of comprehensive sample management solutions for the bioscience industryBioStorage Technologies, Inc. was founded in 2002 and is privately held and headquartered in North America in Indianapolis, Indiana with an additional full-service site in Europe near Frankfurt, Germany. Their missionis to provide their clients with world class, biorepository services, exceeding clients’ expectations of service, value and quality while setting the industry standard for the storage, management & logistics of samples. | $8.3M / Series A / May 29, 2007 |
Co-Investors
About Radius Ventures
Radius Ventures is a venture capital firm that invests in leading-edge, growth equity and expansion-stage health and life sciences companies. The firm is led by a seasoned group of investment professionals with collective experience across all major sectors of the industry, including medical devices, diagnostics, biopharmaceuticals, life sciencetools, healthcare services and healthcare information technology. Radius takes a hands-on approach with each portfolio company by providing intellectual capital, strategic guidance and access to key industry relationships that ultimately increase the odds of success.Founded in 1997, Radius Ventures is based in New York, United States.
Radius Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
James Mead
Partner
|
|||
Edward G. Murphy
Operating Partner
|
|||
George M. Milne
Venture Partner
|
|||
|
Jordan S. Davis
Managing Partner and Co-Founder
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jordan S. Davis invest in?
Jordan S. Davis invests primarily in Health Care, Medical and Biotechnology startups, most often at Series B and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Jordan S. Davis last invest?
The most recent investment recorded for Jordan S. Davis closed in Nov 2015. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
